Peripheral Blood Biomarkers of Chronic Traumatic Brain Injury in Human Subjects – SBIR Direct Phase II (R44) – Aug 29, 2014

BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.

Learn More »

1 Church Street, Suite 801
Rockville, MD 20850
(301) 637-7950
Email

Twitter
Facebook
Linkedin